These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 15112309
1. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC. J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309 [Abstract] [Full Text] [Related]
2. Magnetic resonance spectroscopy on hepatocellular carcinoma after transcatheter arterial chemoembolization. Bian DJ, Xiao EH, Hu DX, Chen XY, Situ WJ, Yuan SW, Sun JL, Yang LP. Chin J Cancer; 2010 Feb; 29(2):198-201. PubMed ID: 20109351 [Abstract] [Full Text] [Related]
3. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ, Li CW, Chuang HY, Liu GC, Wang CK. J Comput Assist Tomogr; 2008 Feb; 32(6):987-94. PubMed ID: 19204465 [Abstract] [Full Text] [Related]
4. In vivo 1H magnetic resonance spectroscopy in evaluation of hepatocellular carcinoma and its early response to transcatheter arterial chemoembolization. Wu B, Peng WJ, Wang PJ, Gu YJ, Li WT, Zhou LP, Tang F, Zhong GM. Chin Med Sci J; 2006 Dec; 21(4):258-64. PubMed ID: 17249202 [Abstract] [Full Text] [Related]
5. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH, Li CF, Li ZF, Zhang K, Wang Q, Yu DX. Chin Med J (Engl); 2009 Jan 05; 122(1):39-43. PubMed ID: 19187615 [Abstract] [Full Text] [Related]
6. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience. Chen CY, Li CW, Kuo YT, Jaw TS, Wu DK, Jao JC, Hsu JS, Liu GC. Radiology; 2006 May 05; 239(2):448-56. PubMed ID: 16569781 [Abstract] [Full Text] [Related]
7. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience. Yuan Z, Ye XD, Dong S, Xu LC, Xiao XS. J Vasc Interv Radiol; 2011 Aug 05; 22(8):1166-73. PubMed ID: 21703872 [Abstract] [Full Text] [Related]
8. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF. J Vasc Interv Radiol; 2006 Mar 05; 17(3):505-12. PubMed ID: 16567675 [Abstract] [Full Text] [Related]
9. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol]. Liu R, Wang JH, Zhou KR, Yan FH, Yan ZP, Shen JZ, Tan YS, Cai Y. Zhonghua Gan Zang Bing Za Zhi; 2005 Oct 05; 13(10):754-8. PubMed ID: 16248948 [Abstract] [Full Text] [Related]
10. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas. Yu JS, Kim JH, Chung JJ, Kim KW. J Magn Reson Imaging; 2009 Jul 05; 30(1):153-60. PubMed ID: 19557734 [Abstract] [Full Text] [Related]
11. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases]. Fan WJ, Zhang L, Ouyang YS. Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2474-7. PubMed ID: 19080627 [Abstract] [Full Text] [Related]
12. [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization]. Xiao YP, Xiao EH, Luo JG, Bian DJ, Li MQ, He Z, Shang QL, Liang B. Zhonghua Zhong Liu Za Zhi; 2008 Dec 16; 30(12):914-6. PubMed ID: 19173992 [Abstract] [Full Text] [Related]
13. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization. Hsieh MY, Lin ZY, Chuang WL. Kaohsiung J Med Sci; 2011 Aug 16; 27(8):314-22. PubMed ID: 21802642 [Abstract] [Full Text] [Related]
14. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization. Wang B, Xu H, Gao ZQ, Ning HF, Sun YQ, Cao GW. Acta Radiol; 2008 Jun 16; 49(5):523-9. PubMed ID: 18568538 [Abstract] [Full Text] [Related]
15. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma]. Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC. Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104 [Abstract] [Full Text] [Related]
16. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography. Kim SH, Lee WJ, Lim HK, Lim JH. J Comput Assist Tomogr; 2007 Mar 24; 31(2):198-203. PubMed ID: 17414753 [Abstract] [Full Text] [Related]
17. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S, Mori M. Eur J Surg Oncol; 2006 Sep 24; 32(7):773-9. PubMed ID: 16797156 [Abstract] [Full Text] [Related]
18. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Arch Surg; 2004 Jul 24; 139(7):766-74. PubMed ID: 15249411 [Abstract] [Full Text] [Related]
19. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization. Kimura S, Okazaki M, Higashihara H, Haruno M, Nozaki Y, Urakawa H, Kora S, Shinagawa Y, Nonokuma M. Hepatogastroenterology; 2009 Jul 24; 56(89):191-8. PubMed ID: 19453056 [Abstract] [Full Text] [Related]
20. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator? Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N. J Magn Reson Imaging; 2008 Apr 24; 27(4):834-9. PubMed ID: 18383261 [Abstract] [Full Text] [Related] Page: [Next] [New Search]